Morepen Laboratories Limited Press Release Apr 01 2025
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Morepen Laboratories Limited has announced that it has received approval for Loratadine export to China, marking a significant milestone in its strategic expansion into the Chinese pharmaceutical market. The approval from China's National Medical Products Administration reinforces Morepen's position as a leading global manufacturer of Loratadine, a widely used anti-allergy drug. Morepen commands a substantial market share in the US generics market for Loratadine and aims to capture a significant share of the Chinese market with this development.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Morepen Laboratories Limited on 6ix
Earlier from Morepen Laboratories
- Press Release Mar 17 2025
- Press Release Jan 28 2025
- Press Release Dec 10 2024
- Press Release Nov 22 2024
- Press Release Nov 11 2024
Later from Morepen Laboratories
- Morepen Laboratories Limited Press Release Apr 11 2025
- Morepen Laboratories Limited Press Release Apr 29 2025
- Morepen Laboratories Limited Press Release May 01 2025
- Morepen Laboratories Limited Press Release May 13 2025
- Press Release (Revised) May 13 2025
Follow Morepen Laboratories into a list and get an email when it puts out news.
Follow Morepen Laboratories